Crospovidone Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

Crospovidone Market Review 2025

The crospovidone market is poised for significant growth in the coming years, driven by the increasing demand for excipients in the pharmaceutical industry, as well as its expanding applications in food and beverage and cosmetic sectors. As a highly effective binder and disintegrant, crospovidone has become integral to various industries, meriting a focused analysis based on current trends, market size, share, and competitive landscape.

As of 2025, the global crospovidone market was valued at approximately USD 352 million. Projections indicate that the market is expected to grow at a CAGR of 6.5% from 2024 to 2030, reaching an estimated USD 480 million by the end of the forecast period. This growth rate reflects the increasing incorporation of crospovidone in pharmaceutical formulations, particularly in oral dosage forms, which underscores its importance as a multifunctional excipient.

The crospovidone market can be segmented by product type into Crospovidone Type A and Crospovidone Type B. In 2025, Crospovidone Type A held the majority market share of around 70%, owing to its higher efficiency in tablet disintegration. On the other hand, Crospovidone Type B is gaining traction, particularly in applications demanding enhanced absorption profiles and consistency.

Key players in the crospovidone market include:

• Ashland
• BASF
• Boai NKY Pharmaceuticals
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
• Jiaozuo Zhongwei Fine Chemical Co., Ltd.
• JH Nanhang Life Science
• Hubei Humanwell Pharmaceutical Co., Ltd.
• Jiangxi Alpha Chemical Co., Ltd.
• Star-Tech Specialty Products
• JRS Specialty Products

The crospovidone market can also be categorized based on manufacturing processes, primarily including the chemical synthesis method and physical blending method. The chemical synthesis method is expected to dominate, accounting for approximately 75% of the market due to the higher purity and performance characteristics offered, which are crucial for pharmaceutical applications.

In terms of application, the market is segmented into pharmaceutical, food & beverage, cosmetics, and others. The pharmaceutical segment dominates the crospovidone market, capturing around 85% of the total share, primarily due to the increasing usage of crospovidone as an excipient in solid dosage forms. The food & beverage sector and cosmetics are emerging markets, expected to grow at rates of 5% to 7% through 2030, as functional food products increase in popularity.

End-use industries for crospovidone include pharmaceuticals, dietary supplements, and personal care products. The pharmaceutical industry remains the largest end-use sector, accounting for more than 80% of total crospovidone consumption. Dietary supplements are emerging as a prominent growth area, anticipated to expand rapidly due to rising consumer health consciousness and demand for high-quality nutritional products.

Geographically, the crospovidone market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America and Europe collectively accounted for over 50% of the global market share, driven by a robust pharmaceutical sector and rigorous regulatory frameworks emphasizing excipient quality. The Asia Pacific region is anticipated to witness the fastest growth, with a CAGR of approximately 8% through 2030, backed by emerging economies like India and China ramping up their pharmaceutical manufacturing capabilities.

Recent developments in regulations and manufacturing practices are shaping the crospovidone market. Authorities like the FDA and EMA are consistently enhancing guidelines pertaining to excipients used in pharmaceutical formulations, which is expected to drive demand for high-quality crospovidone products. Companies are also increasingly focusing on partnerships and collaborations to innovate and enhance product offerings. For instance, BASF's recent investment in R&D aims to develop sustainable manufacturing processes for excipients including crospovidone, in line with global sustainability goals.

Looking forward, it is anticipated that the crospovidone market will continue to witness robust growth through 2030. Segment forecasts indicate:

• The pharmaceutical segment is expected to reach approximately USD 386 million by 2030, expanding at a CAGR of 6.8%.
• Food & Beverage applications could see growth up to USD 39 million, with a CAGR of around 5.5%.
• The cosmetic segment is projected to grow at a rate of 6.0%, driven by increasing demand for natural and organic products.
• The Asia Pacific region may register the highest growth rate, with predictions of reaching USD 203 million by 2030.

In conclusion, the crospovidone market is characterized by its robust growth potential across various industries, particularly in pharmaceuticals and emerging applications in food and cosmetics. Sustained demand for high-quality excipients, innovation, and regulatory advancements will continue to drive this market forward in the coming years.